DOP2002000508A - Composición farmaceutica - Google Patents

Composición farmaceutica

Info

Publication number
DOP2002000508A
DOP2002000508A DO2002000508A DO2002000508A DOP2002000508A DO P2002000508 A DOP2002000508 A DO P2002000508A DO 2002000508 A DO2002000508 A DO 2002000508A DO 2002000508 A DO2002000508 A DO 2002000508A DO P2002000508 A DOP2002000508 A DO P2002000508A
Authority
DO
Dominican Republic
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
DO2002000508A
Other languages
English (en)
Inventor
Mike Yeadon
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to DO2002000508A priority Critical patent/DOP2002000508A/es
Publication of DOP2002000508A publication Critical patent/DOP2002000508A/es

Links

DO2002000508A 2002-11-12 2002-11-12 Composición farmaceutica DOP2002000508A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DO2002000508A DOP2002000508A (es) 2002-11-12 2002-11-12 Composición farmaceutica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DO2002000508A DOP2002000508A (es) 2002-11-12 2002-11-12 Composición farmaceutica

Publications (1)

Publication Number Publication Date
DOP2002000508A true DOP2002000508A (es) 2003-06-15

Family

ID=44261109

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2002000508A DOP2002000508A (es) 2002-11-12 2002-11-12 Composición farmaceutica

Country Status (1)

Country Link
DO (1) DOP2002000508A (es)

Similar Documents

Publication Publication Date Title
FI20011478A0 (fi) Farmaseuttinen koostumus
PT1501534E (pt) Formulacoes farmaceuticas
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
EP1603593A4 (en) PHARMACEUTICAL COMPOSITION
DK1587478T3 (da) Farmaceutisk sammensætning
PL367180A1 (pl) Trwała kompozycja farmaceutyczna
DK3384931T3 (da) Superfin formoterolformulering
DE10393374D2 (de) Zusammensetzung
ATE380544T1 (de) Umhüllte feste darreichungsform
EP1537195A4 (en) DISINFECTING COMPOSITION
FR2862654B1 (fr) Composition amylacee filmogene
EP1425019A4 (en) PHARMACEUTICAL COMPOSITION
NO20050132D0 (no) Vaksinesammensetning
SK4326U (sk) Farmaceutická kompozícia s predĺženým uvoľňovaním
EP1559433A4 (en) STABILIZED COMPOSITION
IS7051A (is) Lyfjasamsetningar
DK1561472T3 (da) Faststofsammensætning
FI20022128L (fi) Farmaseuttinen koostumus
PT1558263E (pt) Composicao farmaceutica de libertacao prolongada
SE0500163L (sv) Sammansättning
EP1561467A4 (en) COMPOSITION FOR RECOVERING DAMAGED SKIN
IS7581A (is) Lyfjasamsetning
NO20034952D0 (no) Farmasöytiske forbindelser
PL377147A1 (pl) Doustna kompozycja
NO20044140D0 (no) New Composition